Location History:
- London, GB (1996 - 2001)
- Dulwich, GB (2002)
Company Filing History:
Years Active: 1996-2002
Title: Goran Karl Claeson: Innovator in Thrombin Inhibition
Introduction
Goran Karl Claeson is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that act as inhibitors or substrates of thrombin. With a total of seven patents to his name, Claeson has established himself as a key figure in pharmaceutical innovation.
Latest Patents
Among his latest patents, Claeson has developed inhibitors and substrates of thrombin. These peptides possess a general structural formula that allows them to effectively inhibit thrombin activity. Additionally, he has created pharmaceutical compositions comprising compounds that inhibit trypsin-like enzymes, showcasing his expertise in designing targeted therapeutic agents.
Career Highlights
Claeson has worked with several prominent organizations throughout his career. Notably, he has been associated with Trigen GmbH and the Thrombosis Research Institute. His work in these institutions has allowed him to advance his research and contribute to the understanding of thrombin and its implications in various medical conditions.
Collaborations
Throughout his career, Claeson has collaborated with esteemed colleagues, including Vijay Vir Kakkar and John Joseph Deadman. These partnerships have facilitated the exchange of ideas and fostered innovation in their shared field of research.
Conclusion
Goran Karl Claeson is a distinguished inventor whose work in thrombin inhibition has led to significant advancements in pharmaceutical science. His contributions continue to impact the field, and his patents reflect his commitment to innovation and research.